PharmacologySpringer Science & Business Media, 1995 M01 26 - 235 pages Since 1975, the Oklahoma Notes have been among the most widely used reviews for medical students preparing for Step 1 of the United States Medical Licensing Examination. Completely revised and updated, these new editions of the Notes feature: More self- assessment questions, geared to the current USMLE format; more tables and figures to promote rapid self-assessment and review; low prices; and coverage of just the information needed to ensure Boards success. |
Contents
GENERAL PRINCIPLES | 1 |
II ABSORPTION OF DRUGS | 8 |
III DISTRIBUTION OF DRUGS | 9 |
IV EXCRETION OF DRUGS | 10 |
VI METABOLISM OF DRUGS | 13 |
VII PHARMACOGENETICS | 16 |
REVIEW QUESTIONS | 18 |
DRUGS ACTING ON THE PERIPHERAL NERVOUS SYSTEM | 26 |
VI ANDROGENS AND ANABOLIC STEROIDS | 145 |
VII ANTERIOR PITUITARY AND HYPOTHALAMUS | 146 |
VIII POSTERIOR PITUITARY HORMONES | 148 |
REVIEW QUESTIONS | 149 |
ANTIINFECTIVE AGENTS | 153 |
II CHEMOTHERAPY OF MICROBIAL DISEASES | 154 |
B VANCOMYCIN | 158 |
D LINCOMYCIN AND CLINDAMYCIN 7chlorolincomycin | 159 |
GANGLIA | 28 |
NEUROMUSCULAR BLOCKING DRUGS | 29 |
SYMPATHETIC DIVISION Adrenergic | 31 |
REVIEW QUESTIONS | 37 |
DRUGS ACTING ON THE KIDNEY | 46 |
II ANTIDIURETIC DRUGS | 50 |
REVIEW QUESTIONS | 53 |
DRUGS ACTING ON THE CARDIOVASCULAR SYSTEM | 55 |
II ANTIANGINAL DRUGS | 56 |
III ANTIARRHYTHMIC DRUGS | 59 |
IV THERAPY OF CONGESTIVE HEART FAILURE | 65 |
V THERAPY OF HYPERLIPOPROTEINEMIAS | 71 |
VI ANTIHYPERTENSIVE THERAPY | 73 |
REVIEW QUESTIONS | 79 |
DRUGS AFFECTING HEMOSTASIS AND HEMATOPOIESIS | 83 |
II ANTIANEMIA DRUGS HEMATINICS | 86 |
REVIEW QUESTIONS | 89 |
DRUGS ACTING ON THE CENTRAL NERVOUS SYSTEM | 90 |
B LOCAL ANESTHETlCS | 92 |
PAIN RELIEF | 94 |
B OPIOID ANTAGONISTS | 96 |
III SEDATIVE HYPNOTICS | 97 |
B BARBITURATES | 98 |
C OTHER AGENTS | 99 |
B PATHOLOGY OF CHRONIC ETHANOL ABUSE | 100 |
C TOXICOLOGY OF OTHER ALCOHOLS | 101 |
B ANTIPARKINSONISM DRUGS | 103 |
C CNS MUSCLE RELAXANTS | 104 |
VI PSYCHOPHARMACOLOGIC DRUGS | 105 |
B ANTIDEPRESSANTS AND LITHIUM | 106 |
C OBSESSIVECOMPULSIVE DISORDER | 108 |
D DRUGS OF ABUSE | 109 |
REVIEW QUESTIONS | 112 |
AUTACOIDS AND THE THERAPY OF INFLAMMATION | 120 |
B SEROTONIN AND SEROTONIN ANTAGONISTS | 123 |
C BRADYKININ | 124 |
III MISCELLANEOUS AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | 130 |
REVIEW QUESTIONS | 132 |
THE ENDOCRINE SYSTEM | 136 |
II ADRENOCORTICAL STEROIDS | 137 |
III PARATHYROID HORMONE AND OTHER FACTORS AFFECTING BONE METABOLISM | 139 |
V OVARIAN HORMONES AND OVULATORY AGENTS | 142 |
E CHLORAMPHENICOL | 160 |
G AMINOGLYCOSIDES | 161 |
H FLUOROQUINOLONES QUINOLONES | 162 |
J URINARY ANTISEPTICS | 164 |
K MISCELLANEOUS ANTIBACTERIAL DRUGS | 165 |
III ANTIFUNGAL AGENTS | 167 |
IV ANTIVIRAL DRUGS | 168 |
V ANTISEPTICS AND DISINFECTANTS | 170 |
REVIEW QUESTIONS | 171 |
CANCER CHEMOTHERAPY AND IMMUNOSUPPRESSIVE AGENTS | 175 |
B ALKYLATING AGENTS | 176 |
D ANTIBIOTICS | 177 |
E ANTIMITOTICS | 178 |
II IMMUNOSUPPRESSIVE AGENTS | 179 |
REVIEW QUESTIONS | 182 |
CHEMOTHERAPY OF PARASITIC DISEASES | 184 |
II METAZOAN INFECTIONS | 187 |
REVIEW QUESTIONS | 190 |
GASTROINTESTINAL DRUGS | 192 |
II LOWER GI DISORDERS | 196 |
RESPIRATORY DRUGS | 201 |
REVIEW QUESTIONS | 203 |
DRUGS ACTING ON THE UTERUS | 204 |
TOXICOLOGY | 208 |
II HEAVY METALS | 209 |
III METAL CHELATING AGENTS | 210 |
IV TERATOGENESIS | 211 |
REVIEW QUESTIONS | 212 |
US DRUG LAWS | 217 |
REVIEW QUESTIONS | 219 |
ANNOTATED ANSWERS TO REVIEW QUESTIONS | 220 |
DRUGS ACTING ON THE PERIPHERAL NERVOUS SYSTEM | 223 |
DRUGS ACTING ON THE KIDNEY | 226 |
DRUGS AFFECTING HEMOSTASIS AND HEMATOPOIESIS | 228 |
AUTACOIDS AND THE THERAPY OF INFLAMMATION | 230 |
THE ENDOCRINE SYSTEM | 231 |
| 232 | |
CANCER CHEMOTHERAPY AND IMMUNOSUPPRESSIVE AGENTS | 233 |
RESPIRATORY DRUGS | 234 |
VITAMINS | 235 |
Other editions - View all
Common terms and phrases
absorbed absorption acid activity acute adrenal adrenoceptors adverse effects agents agonists aldosterone anemia anesthetic angiotensin antagonist antibiotics anticholinergic asthma atropine bacterial benzodiazepines BEST ANSWER binding block blockade blockers blood pressure bone marrow depression calcium cardiac output cardiovascular cause cells cephalosporins chronic contractility decrease Diazepam digitalis disease diuretics dopamine doses drug of choice duration of action enzyme epinephrine excretion following drugs gastric glucocorticoids half-life heart failure heart rate hepatic histamine hormone hypertension hypotension incorrect increase infections inhibit inhibitor insulin intestinal kidney liver Mechanism of action membrane metabolite Metronidazole muscarinic myocardial nausea nerve nervous system norepinephrine occur opioid oral administration orally effective oxygen patients peripheral plasma concentration potential Prazosin produce Propranolol protein reactions receptors release renal reserpine respiratory response REVIEW QUESTIONS side effects smooth muscle sodium solubility stimulation Sulfonamides sympathomimetic symptoms syndrome synthesis tachycardia therapeutic therapy tissue tolerance toxicity treatment tubule Tyramine urinary urine vascular vasoconstriction vasodilation vasopressin ventricular vitamin